Related Experiment Videos

Extremely elevated C-reactive protein levels are associated with unfavourable outcomes, including death, in

Yehonatan Pasternak1, Gilat Livni1, Shai Ashkenazi1

  • 1Department of Paediatrics A, Schneider Children's Medical Centre, Petach Tikva (affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv), Israel.

Insights

Extremely high C-reactive protein (CRP) levels in children indicate serious illness, often infections. These elevated CRP levels are linked to worse outcomes and higher mortality, especially in pediatric oncology patients.

Area of Science:

  • Pediatric Medicine
  • Clinical Chemistry
  • Infectious Diseases

Background:

  • Extremely elevated C-reactive protein (CRP) levels in hospitalized children warrant investigation.
  • Understanding the clinical significance of high CRP is crucial for pediatric patient management.

Purpose of the Study:

  • To investigate the clinical significance of extremely elevated C-reactive protein (CRP) levels in hospitalized children.
  • To determine the association between high CRP levels and clinical outcomes in pediatric patients.

Main Methods:

  • Retrospective analysis of hospitalized children with CRP ≥ 30 mg/dL from 2010-2013.
  • Comparison of clinical data, diagnoses, and outcomes between the study group (high CRP) and control group (other admissions).

Main Results:

  • Patients with CRP ≥ 30 mg/dL had significantly higher mortality and longer hospital stays.
  • Infectious diseases, particularly pneumonia, were the most common diagnoses (89.4%).
  • High CRP correlated with low albumin levels and a crude mortality rate of 17.6% in oncology patients with bacteremia.

Conclusions:

  • Extremely elevated CRP levels in children are strongly associated with severe infections and unfavorable clinical outcomes.
  • High mortality rates are particularly noted in pediatric oncology patients with extremely elevated CRP.
  • Pediatricians must recognize the critical implications of very high CRP levels for timely intervention.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
767
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
545
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
876
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
830